Research Article

Elevated Salivary Inflammatory Biomarkers are Associated with SARS-CoV-2 Infection Severity

Table 1

Demographic and clinical data of the study participants.

CharacteristicFrequency (n and %) value

Non-SARS-CoV-2 (n = 142)Mild SARS-CoV-2 (n = 72)Severe SARS-CoV-2 (n = 86)Mild against severe SARS-CoV-2
Nationality
 Saudi Arabian113 (79.6%)43 (59.7%)44 (51.2%)
 Non-Saudi Arabian29 (20.4%)29 (40.3%)42 (48.8%)
Sex
 Male66 (46.5%)42 (58.3%)75 (87.2%)
 Female76 (53.5%)30 (41.7%)11 (12.8%)
Age (years)
 <202 (1.4%)3 (4.2%)0 (0%)
 20–4072 (50.7%)50 (69.5%)12 (14.0%)
 40–6065 (45.8%)12 (16.7%)50 (58%)
 60–803 (2.1%)6 (8.3%)24 (28%)
 >800 (0%)1 (1.3%)0 (0%)
BMI (kg/m2)
 Under weight (< 18.5)1 (0.7%)1 (1.3%)1 (1.2%)
 Normal weight (18.5–24.9)43 (30.3%)25 (34.8%)10 (11.6%)
 Over weight (25–29.9)60 (42.3%)22 (30.7%)33 (38.4%)
 Obese (≥30)38 (26.7%)23 (31.9%)39 (45.3%)
 Missing0 (0%)1 (1.3%)3 (3.5%)
Chronic diseases
 No diseases108 (76.0%)48 (66.7%)22 (25.6%)
 Diabetes mellitus (DM)15 (10.6%)6 (8.3%)44 (51.2%)
 Hypertension (HT)14 (9.6%)7 (9.7%)32 (37.2%)
 Bronchial asthma5 (3.5%)9 (12.5%)12 (14%)
 Others9 (6.3%)12 (16.7%)18 (20.9%)

Data were presented as frequency (n) and percentage (%).